TESI RAYMOND J 4
4 · SANGSTAT MEDICAL CORP · Filed Sep 15, 2003
Insider Transaction Report
Form 4Exit
TESI RAYMOND J
VP Marketing
Transactions
- Exercise/Conversion
Common Stock
2003-09-11$10.75/sh+2,525$27,144→ 2,525 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−2,525$56,813→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$10.75/sh+7,475$80,356→ 7,475 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−7,475$168,188→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$10.75/sh+10,000$107,500→ 10,000 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−10,000$225,000→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$9.53/sh+2$19→ 2 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−2$45→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$9.53/sh+4,998$47,637→ 4,998 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−4,998$112,455→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$10.20/sh+1,347$13,744→ 1,347 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−1,347$30,308→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$10.20/sh+30,653$312,756→ 30,653 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−30,653$689,693→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$10.20/sh+17,000$173,453→ 17,000 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−17,000$382,500→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$19.38/sh+3,239$62,772→ 3,239 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−3,239$72,878→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$19.38/sh+31,761$615,528→ 31,761 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−31,761$714,623→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$8.07/sh+10,556$85,187→ 10,556 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−10,556$237,510→ 0 total - Exercise/Conversion
Common Stock
2003-09-11$8.07/sh+29,444$237,613→ 29,444 total - Disposition to Issuer
Common Stock
[F1]2003-09-11$22.50/sh−29,444$662,490→ 0 total - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−2,525$56,813→ 0 totalExercise: $10.75From: 2003-09-11Exp: 2010-11-02→ Common Stock (2,525 underlying) - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−7,475$168,188→ 0 totalExercise: $10.75From: 2003-09-11Exp: 2010-11-02→ Common Stock (7,475 underlying) - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−10,000$225,000→ 0 totalExercise: $10.75From: 2003-09-11Exp: 2010-11-02→ Common Stock (10,000 underlying) - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−2$45→ 0 totalExercise: $9.53From: 2003-09-11Exp: 2010-11-16→ Common Stock (2 underlying) - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−4,998$112,455→ 0 totalExercise: $9.53From: 2003-09-11Exp: 2010-11-16→ Common Stock (4,998 underlying) - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−1,347$30,308→ 0 totalExercise: $10.20From: 2003-09-11Exp: 2011-03-01→ Common Stock (1,347 underlying) - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−30,653$689,693→ 0 totalExercise: $10.20From: 2003-09-11Exp: 2011-03-01→ Common Stock (30,653 underlying) - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−17,000$382,500→ 0 totalExercise: $12.99From: 2003-09-11Exp: 2011-06-13→ Common Stock (17,000 underlying) - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−3,239$72,878→ 0 totalExercise: $19.38From: 2003-09-11Exp: 2012-02-20→ Common Stock (3,239 underlying) - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−31,761$714,623→ 0 totalExercise: $19.38From: 2003-09-11Exp: 2012-02-20→ Common Stock (31,761 underlying) - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−10,556$237,510→ 0 totalExercise: $8.07From: 2003-09-11Exp: 2013-02-21→ Common Stock (10,556 underlying) - Exercise/Conversion
Options to Purchase Common Stock
[F1]2003-09-11$22.50/sh−29,444$662,490→ 0 totalExercise: $8.07From: 2003-09-11Exp: 2013-02-21→ Common Stock (29,444 underlying)
Footnotes (1)
- [F1]Option vesting was accelerated and the resulting common stock from the exercise and all outstanding common stock was acquired by Genzyme Corporation ("Genzyme") pursuant to the Agreement and Plan of Merger by and among Genzyme, Swift Starboard Corporation and SangStat Medical Corporation.
Signature
Tamiko F. Lewis, Attorney-in-Fact for Raymond J. Tesi|2003-09-15